Latest filing published 02 Jul 2026 for ALUMIS INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Patrick Machado (board member) discloses dealings in 4 companies, chiefly Arcus Biosciences, Inc., ACELYRIN, Inc. and Alumis Inc. Over a trading history stretching from 3 June 2021 to 30 June 2026, the count stands at 11 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 July 2026 with a share grant in Alumis Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations